Virtus Investment Advisers’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$476K Sell
1,459
-8
-0.5% -$2.61K 0.16% 187
2025
Q1
$396K Buy
+1,467
New +$396K 0.11% 209